Redmond, H Paul <br/><br/>
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.  [electronic resource] 

 -  BMC cancer  Aug 2018 
 - 794 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-018-4641-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers--blood<br/>Chemotherapy, Adjuvant<br/>Colectomy--adverse effects<br/>Colonic Neoplasms--pathology<br/>Female<br/>Humans<br/>Inflammation--blood<br/>Inflammation Mediators--blood<br/>Interleukin-6--blood<br/>Ireland<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--prevention & control<br/>Risk Factors<br/>Surgical Wound Infection--prevention & control<br/>Taurine--administration & dosage<br/>Thiadiazines--administration & dosage<br/>Time Factors<br/>Treatment Outcome